20 Most Shorted Stocks — Short Interest Report July 10, 2026
BookieTrading AI Research Team
AI-generated analysis · Educational purposes only
The latest short interest data reveals significant bearish sentiment across various sectors. We explore the 20 most shorted stocks, assessing their potential for short squeezes and underlying short theses.
20 Most Shorted Stocks
As of July 10, 2026, the short interest data highlights the most shorted stocks across major exchanges. Here’s a detailed analysis of the top 20 stocks, their short interest percentages, and factors influencing their short positions.
1. Groupon Inc (GRPN) - **Short Interest % of Float:** 55.77% - **Days to Cover:** 5.2 - **Bearish Thesis:** Groupon has struggled with declining revenues and increasing competition in the discount retail space. - **Catalysts for Squeeze:** Upcoming earnings report expected on August 1, 2026, could surprise analysts. - **Media Activity:** Limited coverage; potential for increased scrutiny as earnings approach. - **Important Dates:** Earnings release on August 1, 2026. - **Squeeze Risk Score:** 8/10
2. Battalion Oil Corp. (BATL) - **Short Interest % of Float:** 42.88% - **Days to Cover:** 3.1 - **Bearish Thesis:** Concerns over rising operational costs in the oil sector have weighed heavily on BATL. - **Catalysts for Squeeze:** Expected announcements related to new drilling ventures could shift sentiment. - **Media Activity:** Increased coverage as oil prices fluctuate; potential for positive sentiment shift. - **Important Dates:** Q2 earnings on July 28, 2026. - **Squeeze Risk Score:** 7/10
3. C3.ai Inc (AI) - **Short Interest % of Float:** 42.88% - **Days to Cover:** 4.5 - **Bearish Thesis:** Analysts worry about high valuation metrics amidst slowing AI adoption. - **Catalysts for Squeeze:** New product launches and partnerships expected in Q3 2026 could turn the tide. - **Media Activity:** Frequent mentions in tech circles; high-profile endorsements could bolster stock. - **Important Dates:** Product launch event on September 15, 2026. - **Squeeze Risk Score:** 6/10
4. 1-800-FLOWERS.COM, Inc. (FLWS) - **Short Interest % of Float:** 39.91% - **Days to Cover:** 2.9 - **Bearish Thesis:** Market saturation and increased competition in the floral delivery space have raised concerns. - **Catalysts for Squeeze:** Holiday sales results may exceed expectations, especially around Valentine's Day. - **Media Activity:** Limited; however, influencer marketing around holidays could boost visibility. - **Important Dates:** Q2 earnings on August 12, 2026. - **Squeeze Risk Score:** 5/10
5. SoundHound AI Inc (SOUN) - **Short Interest % of Float:** 37.90% - **Days to Cover:** 3.8 - **Bearish Thesis:** Concerns about profitability in a competitive AI landscape. - **Catalysts for Squeeze:** Potential partnerships with major tech firms could shift investor sentiment positively. - **Media Activity:** Increased mentions in tech blogs; potential for influencer endorsement. - **Important Dates:** Earnings on August 5, 2026. - **Squeeze Risk Score:** 7/10
6. Sphere Entertainment Co. (SPHR) - **Short Interest % of Float:** 37.18% - **Days to Cover:** 3.0 - **Bearish Thesis:** Market concerns over declining viewership in traditional entertainment venues. - **Catalysts for Squeeze:** New entertainment launches could attract more viewers. - **Media Activity:** Mixed; however, recent film releases have garnered attention. - **Important Dates:** New release on July 20, 2026. - **Squeeze Risk Score:** 6/10
7. Xponential Fitness, Inc. (XPOF) - **Short Interest % of Float:** 37.11% - **Days to Cover:** 4.0 - **Bearish Thesis:** Concerns over high churn rates in the fitness industry. - **Catalysts for Squeeze:** Upcoming franchise expansion announcements could attract new investors. - **Media Activity:** Increased visibility through fitness influencers. - **Important Dates:** Q2 earnings on August 10, 2026. - **Squeeze Risk Score:** 6/10
8. ARS Pharmaceuticals Inc (SPRY) - **Short Interest % of Float:** 37.04% - **Days to Cover:** 2.5 - **Bearish Thesis:** Concerns regarding FDA approval timelines for key drugs. - **Catalysts for Squeeze:** FDA decision expected in late July 2026. - **Media Activity:** Positive coverage surrounding product efficacy may boost stock. - **Important Dates:** FDA decision on July 25, 2026. - **Squeeze Risk Score:** 9/10
9. Evgo Inc (EVGO) - **Short Interest % of Float:** 34.79% - **Days to Cover:** 3.2 - **Bearish Thesis:** Competition in EV charging infrastructure is intensifying. - **Catalysts for Squeeze:** Partnerships with major automakers could enhance growth prospects. - **Media Activity:** Increased coverage as EV adoption grows. - **Important Dates:** Q2 earnings on August 15, 2026. - **Squeeze Risk Score:** 7/10
10. LifeVantage Corporation (LFVN) - **Short Interest % of Float:** 34.31% - **Days to Cover:** 3.0 - **Bearish Thesis:** Concerns over product efficacy and market competition. - **Catalysts for Squeeze:** New product launches in Q3 2026 might shift investor sentiment. - **Media Activity:** Limited; potential for increased visibility in wellness circles. - **Important Dates:** Product launch on July 30, 2026. - **Squeeze Risk Score:** 5/10
11. Hertz Global Holdings Inc (HTZ) - **Short Interest % of Float:** 34.19% - **Days to Cover:** 4.1 - **Bearish Thesis:** Rising operational costs and competition from ride-sharing services. - **Catalysts for Squeeze:** Financial restructuring announcements could improve outlook. - **Media Activity:** Increased mentions; potential for positive sentiment shift. - **Important Dates:** Q2 earnings on August 5, 2026. - **Squeeze Risk Score:** 6/10
12. Lucid Group, Inc. (LCID) - **Short Interest % of Float:** 33.83% - **Days to Cover:** 3.5 - **Bearish Thesis:** High production costs and delivery delays have troubled investors. - **Catalysts for Squeeze:** New model launches could improve investor confidence. - **Media Activity:** Mixed; strong influencer endorsements could help. - **Important Dates:** Q2 earnings on August 10, 2026. - **Squeeze Risk Score:** 7/10
13. Fluence Energy, Inc. (FLNC) - **Short Interest % of Float:** 32.57% - **Days to Cover:** 2.7 - **Bearish Thesis:** Concerns over profitability in the energy storage sector. - **Catalysts for Squeeze:** New contracts could lead to positive earnings surprises. - **Media Activity:** Growing coverage in renewable energy discussions. - **Important Dates:** Earnings on August 15, 2026. - **Squeeze Risk Score:** 6/10
14. TTEC Holdings, Inc. (TTEC) - **Short Interest % of Float:** 32.22% - **Days to Cover:** 3.2 - **Bearish Thesis:** Competitive pressures in customer service outsourcing have raised concerns. - **Catalysts for Squeeze:** New client acquisitions could shift sentiment. - **Media Activity:** Limited; potential for increased coverage with earnings. - **Important Dates:** Earnings on August 12, 2026. - **Squeeze Risk Score:** 5/10
15. Recursion Pharmaceuticals, Inc. (RXRX) - **Short Interest % of Float:** 32.22% - **Days to Cover:** 3.4 - **Bearish Thesis:** Uncertainty surrounding drug efficacy has led to skepticism. - **Catalysts for Squeeze:** Upcoming trial results could pivot sentiment. - **Media Activity:** Increased discussions in biotech forums. - **Important Dates:** Results announcement on August 5, 2026. - **Squeeze Risk Score:** 7/10
16. Purecycle Technologies Inc (PCT) - **Short Interest % of Float:** 31.67% - **Days to Cover:** 2.8 - **Bearish Thesis:** High operational costs and competition in recycling technology. - **Catalysts for Squeeze:** New partnerships could shift investor sentiment positively. - **Media Activity:** Limited, but potential for increased visibility. - **Important Dates:** Earnings on August 10, 2026. - **Squeeze Risk Score:** 5/10
17. Urban One, Inc. (UONE) - **Short Interest % of Float:** 31.40% - **Days to Cover:** 1.5 - **Bearish Thesis:** Struggles in the media sector have raised investor concerns. - **Catalysts for Squeeze:** New content initiatives could bolster viewership. - **Media Activity:** Limited; potential for increased visibility with new content. - **Important Dates:** Q2 earnings on August 1, 2026. - **Squeeze Risk Score:** 4/10
18. Serve Robotics Inc. (SERV) - **Short Interest % of Float:** 31.02% - **Days to Cover:** 3.0 - **Bearish Thesis:** Competition in the robotics delivery space is increasing. - **Catalysts for Squeeze:** Partnerships with major retailers could enhance growth. - **Media Activity:** Growing interest in automation; potential for influencer endorsements. - **Important Dates:** Q2 earnings on August 12, 2026. - **Squeeze Risk Score:** 5/10
19. GeneDx Holdings Corp. (WGS) - **Short Interest % of Float:** 30.92% - **Days to Cover:** 3.1 - **Bearish Thesis:** Concerns over competition in genetic testing. - **Catalysts for Squeeze:** New testing technology announcements could shift investor sentiment. - **Media Activity:** Increased coverage in health tech forums. - **Important Dates:** Earnings on August 10, 2026. - **Squeeze Risk Score:** 6/10
20. LifeVantage Corporation (LFVN) - **Short Interest % of Float:** 34.31% - **Days to Cover:** 3.0 - **Bearish Thesis:** Concerns over product efficacy and heavy competition in the market. - **Catalysts for Squeeze:** Upcoming product launches could surprise the market. - **Media Activity:** Limited; potential for increased exposure around product launches. - **Important Dates:** Launch on September 1, 2026. - **Squeeze Risk Score:** 5/10
Top 3 Most Dangerous Shorts 1. **ARS Pharmaceuticals Inc (SPRY)** - High potential for a squeeze due to FDA decision. 2. **C3.ai Inc (AI)** - New product launches could shift sentiment. 3. **Groupon Inc (GRPN)** - Earnings surprise potential could trigger a rally.
Short of the Week **ARS Pharmaceuticals Inc (SPRY)** stands out as the most at-risk short position, with an impending FDA decision that could lead to a significant price movement.
Pattern Analysis This short interest data indicates a mix of sector-wide trends, especially in technology and biotechnology, alongside stock-specific issues. The high short interest in these sectors suggests broader concerns about valuation and growth prospects, alongside company-specific challenges.
Educational content only. Not financial advice. DYOR.
⚠️ Educational Content Only. This article is AI-generated for informational and educational purposes. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security or digital asset. Always conduct your own research and consult a qualified financial advisor before making investment decisions.